Qiagen NV (Qiagen NV) EBIT per Share

: $2.17 (TTM As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

Qiagen NV's EBIT per Share for the three months ended in Dec. 2023 was $0.59. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $2.17.

During the past 12 months, the average EBIT per Share Growth Rate of Qiagen NV was -22.90% per year. During the past 3 years, the average EBIT per Share Growth Rate was -5.60% per year. During the past 5 years, the average EBIT per Share Growth Rate was 12.00% per year. During the past 10 years, the average EBIT per Share Growth Rate was 22.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Qiagen NV's EBIT per Share or its related term are showing as below:

QGEN' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -30.6 Med: 16.45 Max: 67.2
Current: -5.6

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Qiagen NV was 67.20% per year. The lowest was -30.60% per year. And the median was 16.45% per year.

QGEN's 3-Year EBIT Growth Rate is ranked worse than
62.57% of 179 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.7 vs QGEN: -5.60

Qiagen NV's EBIT for the three months ended in Dec. 2023 was $131 Mil.

Qiagen NV EBIT per Share Historical Data

The historical data trend for Qiagen NV's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qiagen NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

-0.02

2.25

3.02

2.56

2.16

Qiagen NV Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBIT per Share	Get a 7-Day Free Trial															0.54	0.56	0.52	0.50	0.59

Qiagen NV EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Qiagen NV's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	483.219	/	223.700
=	2.16

Qiagen NV's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	131.317	/	223.820
=	0.59

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.17

Qiagen NV (NYSE:QGEN) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Qiagen NV EBIT per Share Related Terms

Thank you for viewing the detailed overview of Qiagen NV's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Qiagen NV (Qiagen NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen NV (NYSE:QGEN) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

1QGEN:Italy QIAd:UK 0RLT:UK QIA:Germany QIA:Germany QIA:Germany QIA:Germany QGEN:Austria

Address

Hulsterweg 82, Venlo, LI, NLD, 5912 PL

Website

https://www.qiagen.com

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (over 45% of 2022 sales), followed by EMEA (nearly 35%), and Asia-Pacific (nearly 20%).

Executives